| |
|
|
|
VistaGen Therapeutics Inc.  
|
|
1.12 -0.01 (-0.01%) |
04-18 16:00 |
|
Open: |
1.13 |
Pre close: |
1.13 |
Target:
|
1.49
|
|
High: |
1.19 |
Low: |
1.11 |
Resistance:
|
1.28
1.38
|
|
Volume: |
153,102 |
Market Cap: |
48M |
Support:
|
1.11
0.92
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.14
 |
MACD |
MACD(12,26):
|
-0.04 |
|
MA(20): |
1.22 |
Signal(12,26,9): |
-0.03 |
|
MA(100): |
1.46 |
Stochastic Oscillator |
%K(14,3):
|
9.72 |
|
MA(250): |
1.45  |
%D(3): |
11.18 |
|
Average Volume(K) |
3-Month: |
31301
|
52-Week |
High:
|
2.44 |
|
10-Days: |
17977 |
Low: |
0.81 |
|
RSI |
RSI(14):
|
35.26 |
Change(%): |
19.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.160 |
Return on Equity (ttm) |
-402.7 |
Shares Out. (M) |
41.12 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-221.1 |
Shares Float (M) |
39.67 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
6.30 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
11.70 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
31.900 |
EBITDA (p.s.) |
0.000 |
P/E |
-0.97 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.04 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-13.57 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-5.55 |
P/CF |
-3.39 |
|
|
|
|
|
|
